Articles

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

Sunnybrook Health Sciences Centre, Toronto, ON
Tom Baker Cancer Centre, Calgary, AB
University of Alberta, Edmonton, AB
QEII Health Sciences Centre, Halifax, NS
The Ottawa Hospital, Ottawa, ON
The Ottawa Hospital, Ottawa, ON
Juravinski Cancer Centre, Hamilton, ON
Juravinski Cancer Centre, Hamilton, ON
Dr. Georges-L-Dumont University Hospital Centre, Moncton, NB
Dr. Georges-L-Dumont University Hospital Centre, Moncton, NB
Jewish General Hospital, Montreal, QC
Princess Margaret Cancer Centre, Toronto, ON
McGill University Health Centre, Montreal, QC
Vancouver General Hospital, Vancouver, BC
CHU de Québec-Université Laval, Quebec City, QC
Saskatoon Cancer Agency, Saskatoon, SK
Cancer Care Manitoba, Winnipeg, MB
Cancer Care Manitoba, Winnipeg, MB
Sunnybrook Health Sciences Centre, Toronto, ON
Sunnybrook Health Sciences Centre, Toronto, ON
Sunnybrook Health Sciences Centre, Toronto, ON
Sunnybrook Health Sciences Centre, Toronto, ON
Sunnybrook Health Sciences Centre, Toronto, ON
St. Paul’s Hospital, Vancouver, BC
Sunnybrook Health Sciences Centre, Toronto, ON
Vol. 108 No. 2 (2023): February, 2023 https://doi.org/10.3324/haematol.2022.280723